Baylor to Use Illumina's Infinium Products in Developmental Diseases Studies | GenomeWeb

NEW YORK (GenomeWeb News) – The Baylor College of Medicine's Medical Genetics Laboratories will use Illumina's Infinium High-Density DNA Analysis products in genomic studies of developmental disorders.

Specifically, the Houston-based lab intends to use Illumina's arrays for studying genomic imprinting and its role in developmental diseases such as Prader-Willi syndrome, Angelman syndrome, and other disorders caused by uniparental disomy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.